Difficulty: Medium
Average Score: 70%
Practice
A 33 year old lady with type 2 diabetes mellitus presents in early pregnancy. Which of the following is most appropriate?
Correct answer
B
Rationale
In early pregnancy, it is crucial for women with diabetes mellitus to carefully manage their medications to ensure the best outcomes for both the mother and the developing fetus. The correct answer, option B, stating that the lady must convert to insulin therapy, is the most appropriate choice in this scenario.
During the early stages of pregnancy, sulphonylurea drugs are not recommended due to their potential risks to the developing fetus. Insulin therapy is considered the safest option for managing blood glucose levels in pregnant women with diabetes. Insulin does not cross the placenta, making it the preferred choice to maintain tight glycemic control without posing harm to the fetus.
Option A is incorrect because continuing sulphonylurea drugs can increase the risk of adverse outcomes for the fetus. Option C, stopping all treatment, is dangerous as uncontrolled blood sugar levels can lead to serious complications for both the mother and the baby. Option D, converting to diet only, is inadequate for managing diabetes during pregnancy as it may not provide sufficient control over blood glucose levels.
Educationally, it is important for healthcare providers to be aware of the appropriate management strategies for pregnant women with diabetes to optimize outcomes. Understanding the risks and benefits of different treatment options is essential in providing safe and effective care for this population. Insulin therapy remains the cornerstone of management for pregnant women with diabetes to ensure the best possible health for both the mother and the unborn child.
During the early stages of pregnancy, sulphonylurea drugs are not recommended due to their potential risks to the developing fetus. Insulin therapy is considered the safest option for managing blood glucose levels in pregnant women with diabetes. Insulin does not cross the placenta, making it the preferred choice to maintain tight glycemic control without posing harm to the fetus.
Option A is incorrect because continuing sulphonylurea drugs can increase the risk of adverse outcomes for the fetus. Option C, stopping all treatment, is dangerous as uncontrolled blood sugar levels can lead to serious complications for both the mother and the baby. Option D, converting to diet only, is inadequate for managing diabetes during pregnancy as it may not provide sufficient control over blood glucose levels.
Educationally, it is important for healthcare providers to be aware of the appropriate management strategies for pregnant women with diabetes to optimize outcomes. Understanding the risks and benefits of different treatment options is essential in providing safe and effective care for this population. Insulin therapy remains the cornerstone of management for pregnant women with diabetes to ensure the best possible health for both the mother and the unborn child.